✦ LIBER ✦

EXPECT (EXelon Patch EffeCtiveness Trial): Effectiveness and tolerability of transdermal rivastigmin in daily practice

✍ Scribed by Articus, Konstantin; Hechenbichler, Klaus; Bornholdt, Klaus

Book ID: 123335173
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 98 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2235

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Compliance of patients with Alzheimer's

Compliance of patients with Alzheimer's disease to treatment with transdermal rivastigmine and its effectiveness and tolerability in daily practice

✍ Adler, Georg; Articus, Konstantin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Safety and tolerability of rivastigmine

Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials

✍ C. H. Sadowsky; M. R. Farlow; X. Meng; J. T. Olin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Effectiveness and tolerability of rotigo

Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany

✍ Stiasny-Kolster, Karin; Berg, Daniela; Hofmann, Werner E.; Berkels, Reinhard; Gr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 556 KB

Assessing the cost-effectiveness of the

Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models

✍ Balázs Nagy; Alan Brennan; Ágnes Brandtmüller; Simu K. Thomas; Sean D. Sullivan; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

Assess long-term cost-effectiveness of rivastigmine patch in Alzheimer's disease (AD) management in the UK, using cognitive and functional models based on clinical trial efficacy data. Methods: Incremental costs and Quality Adjusted Life Years (QALYs) associated with rivastigmine patch and capsule t

Real-World Cost-Effectiveness of Oxalipl

Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

✍ Gils, Chantal W. M.; Groot, Saskia; Redekop, William K.; Koopman, Miriam; Punt, 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 488 KB

Efficacy of the 13.3 mg/24 h rivastigmin

Efficacy of the 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study: Prospective subgroup analysis by disease severity and time-to-meet decline

✍ Black, Sandra; Bakchine, Serge; Bellelli, Giuseppe; Molinuevo, Jose Luis; Downs, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB